Your browser doesn't support javascript.
loading
Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy.
Delgado-Tirado, Santiago; Amarnani, Dhanesh; Zhao, Guannan; Rossin, Elizabeth J; Eliott, Dean; Miller, John B; Greene, Whitney A; Ramos, Leslie; Arevalo-Alquichire, Said; Leyton-Cifuentes, David; Gonzalez-Buendia, Lucia; Isaacs-Bernal, Daniela; Whitmore, Hannah A B; Chmielewska, Natalia; Duffy, Brandon V; Kim, Eric; Wang, Heuy-Ching; Ruiz-Moreno, Jose M; Kim, Leo A; Arboleda-Velasquez, Joseph F.
Afiliação
  • Delgado-Tirado S; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Amarnani D; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Zhao G; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Rossin EJ; Retina Service, Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Eliott D; Retina Service, Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Miller JB; Retina Service, Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Greene WA; Sensory Trauma Task Area, United States Army Institute of Surgical Research, Fort Sam Houston, San Antonio, USA.
  • Ramos L; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Arevalo-Alquichire S; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Leyton-Cifuentes D; Energy, Materials and Environment Group, Faculty of Engineering, Universidad de La Sabana, Chia, Colombia.
  • Gonzalez-Buendia L; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Isaacs-Bernal D; Universidad EIA, Envigado, Colombia.
  • Whitmore HAB; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Chmielewska N; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Duffy BV; Energy, Materials and Environment Group, Faculty of Engineering, Universidad de La Sabana, Chia, Colombia.
  • Kim E; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Wang HC; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Ruiz-Moreno JM; Boston College, Boston, USA.
  • Kim LA; Schepens Eye Research Institute of Massachusetts Eye and Ear and the Department of Ophthalmology at Harvard Medical School, Boston, USA.
  • Arboleda-Velasquez JF; Harvard College, Cambridge, USA.
Sci Rep ; 10(1): 20554, 2020 11 30.
Article em En | MEDLINE | ID: mdl-33257736

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação da Expressão Gênica / Vitreorretinopatia Proliferativa / Subunidade alfa 2 de Fator de Ligação ao Core / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulação da Expressão Gênica / Vitreorretinopatia Proliferativa / Subunidade alfa 2 de Fator de Ligação ao Core / Transição Epitelial-Mesenquimal Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article